PurposeThe purpose of this article is to examine the relationship between work value PO fit with fit being operationalized as a same‐source or different‐source measure.Design/methodology/approachA sample of 94 employees from a company located in Curac¸ao completed a questionnaire in which they rated their personal work values, their perceptions of the work values of the organization, and their turnover intention.FindingsThe different‐source work value fit measure was significantly and more strongly related to turnover intention than the same‐source work value fit measure.Research limitations/implicationsThis study underscores the need for a careful reflection on the content and operationalization of fit measures.Practical implicationsManagers are able to manage the fit of their employees by creating positive group level perceptions of the work environment.Originality/valueThis study examines the effects of different fit measures on individuals' turnover intention. Moreover, work values fit was investigated.

A transparent procedure has resulted in an updateable tool to produce individual ranking of antipsychotics based on the patients' input.

No abstract

Background Subjective response (SR) to antipsychotic medication is relevant for quality of life, adherence and recovery. Here, we evaluate (1) the extent of variation in SR in patients using a single antipsychotic; (2) the association between subjective and symptomatic response; and (3) predictors of SR. Methods Open-label, single treatment condition with amisulpride in 339 patients with a first episode of a schizophrenia spectrum disorder, at most minimally treated before inclusion. Patients were evaluated at baseline, before start with amisulpride and after four weeks of treatment with the Subjective Wellbeing under Neuroleptic scale, the Positive and Negative Syndrome Scale, and the Calgary Depression Scale for Schizophrenia. Results (1) 26.8% of the patients had a substantial favorable SR, and 12.4% of the patients experienced a substantial dysphoric SR during treatment with amisulpride. (2) Modest positive associations were found between SR and 4 weeks change on symptom subscales (r = 0.268–0.390, p values < 0.001). (3) Baseline affective symptoms contributed to the prediction of subjective remission, demographic characteristics did not. Lower start dosage of amisulpride was associated with a more favorable SR (r = −0.215, p < 0.001). Conclusions We conclude that variation in individual proneness for an unfavorable SR is substantial and only modestly associated with symptomatic response. We need earlier identification of those most at risk for unfavorable SR and research into interventions to improve SR to antipsychotic medication in those at risk.